Skip to Content
Addiction Help

Our Mobile Medication Unit is Now Serving Patients in Greensboro! Join Us On The Road To Recovery Today!

Get Help Now
  • 1-877-284-7074
X

Digital Pre-Admission Form

Page 1 of

We’re excited to welcome new patients to begin the induction process by completing the Intake Form below. Submitting this form will streamline your first appointment, saving you valuable time—up to an hour—and providing faster access to medication and relief.

Please note that the form MUST be completed by the patient only and filled out in a single session. Rest assured, your information will remain secure throughout the process. To complete the form, you should have the following (if you do not, we will work with you and address these during your appointment):

  • Picture of ID
  • Picture of Insurance Card

If you have any questions, please contact telehealth@cmglp.com.

Thank you for choosing New Season as your partner in your recovery journey! You have taken the courageous first step in seeking treatment for opioid addiction and we look forward to walking alongside you every step of the way.

- Please enter the patient's first name below.
- Please enter the patient's last name below.
- Please enter the patient's birth date below.
- Please enter the patient's social security number below.
- Please enter the patient's address below.
- Please enter the patient's city below.
- Please enter the patient's state below.
- Please enter the patient's zip code below.
- Please enter the patient's county below.
- Please enter the patient's phone below.
- Please enter the patient's gender below.
- Please enter the patient's race below.
- Please enter the patient's hair color below.
- Please enter the patient's eye color below.
- Please enter the patient's weight below.
- Please enter the patient's height below.
- Please enter the patient's marital status below.
- Please enter the patient's employment status below.

Do you have insurance?
- Please indicate whether you have insurance.

At New Season, we are dedicated to removing financial barriers to treatment by partnering with a wide range of insurance providers nationwide. While we continually strive to expand our network of insurance partners, please note that we may not currently accept all insurance plans, including yours.

Please provide your insurance information below so we can verify whether your plan is accepted.


- Please enter the patient's emergency contact name below.
- Please enter the patient's emergency contact phone number below.
- Please enter the emergency contact's relationship to patient below.

Please choose a location below.
Overview

Acknowledgement of Use & Disclosure of Protected Health Information for Treatment, Payment, or Health Care Operations under HIPAA.

Patient Acknowledgement

I consent to the use or disclosure of my individually identifiable health information as described below. I understand that this consent is voluntary, and that New Season, the covered entity as described under HIPAA, may refuse to provide services if I revoke this consent.

I understand that my individually identifiable health information may be used and disclosed to carry out treatment, payment, or health care operations including medical screening, evaluation and physicals, case management, counseling, dosing, treatment planning, discharge/transition planning, and referral.

I understand that the organization's Notice of Privacy Policy provides a more complete description of the types of uses and disclosures, and that I should review the notice and hereby acknowledge that I received it before signing this consent.

I understand that the terms of the organization's Notice of Privacy practices may change at any time. Before a significant change in policies, New Season will amend its notice and post a new notice in the waiting area of each clinic and on its web site. I can also request copies of the notice at any time. If I request additional information about the privacy practices employed at this clinic, I will contact the program administrator.

I understand that I may request that New Season restrict how my individually identifiable health information is used or disclosed to carry out treatment, payment, or health care operations. New Season is not required to agree to requested restrictions, but if New Season agrees to a requested restriction, the restriction is binding on New Season, and its assigns.

I understand that I may revoke my consent at any time by notifying New Season, in writing, except to the extent New Season has taken action in reliance on the consent.


I hereby authorize and give voluntary consent to the Medical Director, and/or any appropriately authorized assistants they may select, to administer or order approved opioid agonist medications as an element in the treatment for my dependence on heroin or other narcotic drugs.

The procedures to treat my condition have been explained to me, and I understand that it will involve my taking the ordered narcotic drug at the schedule determined by the Medical Director, or their designee, which will help control my dependence on heroin or other narcotic drugs.

It has been explained to me that opioid agonist medications are narcotic drugs, which can be harmful if taken without medical supervision. I further understand that they are addictive medications and may, like other drugs used in medical practice, produce adverse results. The alternative method of treatment, the possible risks involved, and the possibilities of complications have been explained to me, but I still desire to receive treatment due to the risk of my return to heroin or other narcotic drugs.

The goal of narcotic treatment is total rehabilitation of the patient. Eventual withdrawal from the use of all drugs is an appropriate treatment goal. I realize that for some patients, narcotic treatment may continue for relatively long periods of time, but that periodic consideration shall be given concerning my complete withdrawal from the use of all narcotic drugs.

I understand that I may withdraw from this treatment program and discontinue the use of the drug at any time, and I shall be afforded medically supervised withdrawal.

I agree to immediately inform any doctor who may treat me for any other medical problem that I am enrolled in an opioid treatment program. I understand that the use of other drugs in conjunction with those drugs ordered by the treatment program could cause me serious harm or even death. I agree that I will inform the treatment program’s doctor of any and all other drugs that I am currently taking and/or that I may take while receiving treatment services at the clinic.

I also understand that during the course of treatment, certain conditions may make it necessary to use additional or different procedures than those explained to me. I understand that these alternate procedures shall be used when, in the Medical Director’s professional judgment, it is considered advisable

Finally, I agree and acknowledge that any dispute between me and either the Medical Director or their affiliates, including will be resolved pursuant to the binding arbitration provisions that I agreed to in Section 20 of the Patient Informed Consent Form between me and and that I have waived my right to seek resolution of any such claims in a court of law.


The administration of opioid agonist medication is the specialized treatment provided by the outpatient opioid treatment program (“OTP”) centers operated by Colonial Management Group, L.P. d/b/a New Season Treatment Center (“New Season”). One of your rights as a patient is to be fully informed regarding all aspects of your treatment, including the use of your Protected Health Information (“PHI”). This form provides critical information about your treatment that you must acknowledge by your signature before we can provide treatment to you.

  1. As part of your treatment, we will be ordering approved opioid agonist medications for you.
  2. Opioid agonist medications are habit-forming narcotic substances that will stop you from becoming sick from withdrawal. It will also stop any cravings you may have for other narcotics, such as heroin, morphine, and dilaudid.
  3. Medication will be ordered for you by a physician and administered to you by a nurse or pharmacist. It will be necessary for you to take this medication as directed by your New Season treatment team while you are in treatment;
  4. Opioid agonist medications are highly habit-forming. As a result, you will become physically dependent upon these medications. Because you will become dependent, it will be necessary to slowly reduce your daily dose under medical supervision (this process is known as “medically supervised withdrawal”). Abruptly stopping of your directed doses of medication can cause you to go into withdrawal.
  5. You have the right to discontinue treatment at any time. If, however, you choose to discontinue treatment without the benefit of medically supervised withdrawal, you will likely experience withdrawal symptoms and become ill. Although medication withdrawal symptoms are not generally life-threatening, they are extremely unpleasant and can be avoided by gradually reducing your daily dose.
  6. Some of the side effects of opioid agonist medications are constipation, sweating, nausea, lightheadedness, sleepiness, dizziness, urine retention or slowness, and/or skin rash. All of these side effects are temporary and will pass as your body becomes tolerant to the medication. If you experience any of the aforementioned side effects, we strongly advise you not to drive or operate any machinery.
  7. When taken as ordered by the treatment center’s Medical Director, opioid agonist medications are safe. You can, however, experience physical problems that might require hospitalization if you use other drugs while taking opioid agonist medications. For example, the use of painkillers, tranquilizers, anti-depressants, alcohol, or any other central-nervous system depressant can cause respiratory distress, hypotension (inadequate blood pressure), over-sedation, coma, and even death if taken in conjunction with an opioid agonist medication.
  8. Because other prescription medications do not interact well with opioid agonist medications, you must inform any physician or dentist treating you that you are taking prescribed opioid agonist medications. Specifically, some medications such as Talwin, Nubain, Stadol, Rifampin, Dilantin, many barbiturates, and medications prescribed for HIV/AIDS can cause immediate withdrawal symptoms. It is absolutely critical that you inform your other treating physicians and dentists regarding your treatment for opioid use disorder so that appropriate medications can be prescribed for you.
  9. A pregnant mother and their developing baby can safely receive opioid agonist medications. The developing baby is at most risk when its mother continues to use other drugs. Withdrawal from certain drugs causes uterine contractions that could lead to premature delivery or spontaneous miscarriage. If you are pregnant, you must inform your OB-GYN physician that you are in treatment for opioid use disorder and have been prescribed an opioid agonist medication.
  10. You will be assigned a counselor or case manager to coordinate your treatment and assist in the development of an individualized treatment plan. You will be expected to work with your counselor/case manager in developing the plan and identifying realistic treatment goals and objectives. Your progress in treatment will be determined by the degree to which you work on/accomplish your treatment goals and objectives. You will also be expected to work with your counselor/case manager to develop a transition/discharge plan if you leave the program.
  11. You will be permitted to request adjustments in your daily dose of medication consistent with your comfort level. The treatment center’s Medical Director, however, has the ultimate and final responsibility regarding the amount of medication you receive at any given time.
  12. You will not be forced to undergo medically supervised withdrawal from opioid agonist medications until such time as you are ready to do so. If, however, you violate the OTP center’s rules, and the Medical Director and treatment staff determine that you cannot continue in treatment, you will be required to undergo medically supervised withdrawal. If you wish to undergo medically supervised withdrawal, you should inform your counselor/case manager of your desire to do so. You will be asked to participate in the planning of the medically supervised withdrawal process and, specifically, the length and timing of the process.
  13. If you know upon admission that you want to undergo medically supervised withdrawal or detoxification, you should tell your counselor/case manager when you work with them to develop your individualized treatment plan.
  14. You will always be informed about your daily dose.
  15. New Season recognizes that treatment is not the same for all patients. While we encourage total, permanent, lifelong abstinence from all drugs for all patients, we also recognize that patients may vary significantly in their treatment goals, objectives, and individual approaches to treatment, recovery, sobriety, and abstinence. Therefore, your counselor/case manager will actively work with you to develop an Individualized Treatment Plan that reflects your personal needs and preferences.
  16. You have the right to request a change to your treatment plan at any time simply by expressing your desires to your counselor/case manager;
  17. The treatment center’s Medical Director, nurses, pharmacist, and your counselor/case manager are available to answer any questions you may have about your treatment experience.
  18. We may not be able to provide services to you if you are arrested and/or incarcerated.
  19. Your PHI is protected under federal and state law. This means that New Season will not release your PHI to anyone unless lawfully allowed to do so. In order to coordinate your treatment with other healthcare providers and your health insurer, New Season requires your consent to share your PHI for Treatment, Payment and Operational purposes. Treatment means that New Season can share your PHI with other medical and behavioral health providers who are treating you. Payment means that New Season can use your PHI to bill your health insurer for the treatment services it provides to you. Operations means that New Season can use your PHI to improve your care, contact you when necessary, and run our operations. By signing this Patient Informed Consent form, you give New Season permission to use your PHI for Treatment, Payment and Operational purposes only. A copy of New Season’s Notice of Privacy Practice, which fully explains all of your rights regarding your PHI, is available to you upon request, and also is available on New Season’s website at https://www.newseason.com/notice-of-privacy-practices/.
  20. The treatment center staff are required to report communicable diseases including Tuberculosis (but excluding the HIV virus) to designated public health authorities. Should your laboratory tests indicate that you have a communicable disease, we will notify you and the public health department of the test results. Should you have a communicable disease, you will have the option of seeking treatment from your physician or the local public health department. You will be expected to seek treatment for your disease as a condition of remaining in treatment with New Season, and you will be asked to provide verification that you did receive treatment. If you refuse to seek treatment for any communicable disease, you may be required to undergo a medically supervised withdrawal from opioid agonist medications and be discharged from treatment. Your counselor/case manager will assist you if this situation does arise. Your agreement with these provisions is a required condition of admission to our treatment program.
  21. You agree that any dispute between us regarding your treatment including, but not limited to, claims of medical malpractice, professional liability, negligence, intentional acts, or any other type of relief in any way pertaining to your treatment at New Season, will be determined by submission to arbitration in accordance with the Federal Arbitration Act. Any such claims shall be resolved by arbitration solely between you and New Season, and not together with the claims of any one or more other patients. By signing this Patient Informed Consent form, you are agreeing to resolve any dispute you have with New Season through arbitration, which shall be your sole legal remedy. Arbitration under this agreement shall be a binding arbitration administered by JAMS Alternative Dispute Resolution service by a single neutral arbitrator at a mutually-agreed upon location, or, if we are unable to agree, at a location in the state where you where you received your treatment. You are encouraged to ask questions or seek legal counsel if you do not understand any of the provisions of this paragraph.
    1. New Season reserves the right to terminate patients from treatment involuntarily, i.e., without their permission or consent. Specifically, we retain the right to discharge you from treatment if you:
      1. continue to use other drugs (including alcohol);
      2. willingly refuse to comply with program rules and regulations;
      3. sell, attempt to sell, or otherwise divert any of your medication;
      4. become verbally or physically abusive to staff or other patients;
      5. fail to responsibly pay for your medication; or
      6. become or remain disruptive to the program or to other patients, or interfere with program operations, your treatment, or the treatment of other patients.
    2. In the event that the staff is contemplating your involuntary discharge from the OTP, you will be notified of the decision and, in response, will have the right to:
      1. discuss the reasons for the discharge decision with the treatment center’s Program Director;
      2. request assistance with arranging a transfer to another OTP;
      3. negotiate the length of your medically supervised withdrawal; and
      4. register a complaint with the State Opioid Treatment Authority/regulatory agency;
  22. New Season reserves the right to withhold treatment if you appear to be intoxicated or under the influence of any drug.
  23. You are expected to play a key role in your treatment. Your counselor/case manager is your primary point of contact for all matters and questions pertaining to your treatment plan and all services that you receive from the treatment center staff.
Informed Consent Acknowledgement

I acknowledge that I have read and understand the Patient Informed Consent Form and its contents.

Please provide a signature.
Clear - Please sign the Acknowledgment of Services Offered section.
Date: 11/19/2025

This Notice of Privacy Practices (the “Notice”) describes:

  • HOW HEALTH INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED;
  • YOUR RIGHTS WITH RESPECT TO YOUR HEALTH INFORMATION; AND
  • HOW TO FILE A COMPLAINT CONCERNING A VIOLATION OF THE PRIVACY OR SECURITY OF YOUR HEALTH INFORMATION, OR OF YOUR RIGHTS CONCERNING YOUR INFORMATION.

YOU HAVE A RIGHT TO A COPY OF THIS NOTICE (IN PAPER OR ELECTRONIC FORM) AND TO DISCUSS IT WITH OUR PRIVACY OFFICER AT 407.351.7080 EXT. 11140 OR bill.sutton@cmglp.com IF YOU HAVE ANY QUESTIONS.

You have the right to:

  • Get a copy of your paper or electronic medical record
  • Make corrections to your paper or electronic medical record
  • Request confidential communication about your treatment
  • Ask us to place restrictions on the information we share, including disclosures made with your prior consent for purposes of treatment, payment or healthcare operations
  • Revoke any previous written consent that you gave for the use or disclosure of your health information
  • Get a list of those with whom we’ve shared your health information for the past three years
  • Get a copy of this Notice
  • Discuss this Notice with a designated contact person from our organization
  • Not receive any fundraising communications
  • File a complaint if you believe your privacy rights have been violated

When it comes to your health information, you have certain rights. This section explains your rights and some of our responsibilities.

Get an electronic or paper copy of your medical record

  • You can ask to see or get an electronic or paper copy of your medical record and other health information we have about you. Ask us how to do this.
  • We will provide a copy or a summary of your health information, usually within thirty (30) days of your request. We may charge a reasonable, cost-based fee to produce these records which may be determined by applicable state laws or regulations.

Ask us to correct your medical record

  • You can ask us to correct health information about you that you think is incorrect or incomplete. Ask us how to do this.
  • We may say “no” to your request, but we’ll explain to you why in writing within sixty (60) days of your request.

Request confidential communications

  • You can ask us to contact you in a specific way (for example, by calling your home or cell phone) or to send mail to a different address.
  • We will agree to all reasonable requests.

Ask us to limit what we use or share

  • You have the right to ask us to restrict the use or disclosure of your health information for treatment, payment, or our operations. We are not required to agree to your request, particularly if your request will adversely impact your treatment or if your health information is needed to provide emergency medical treatment to you.
  • If you give us your written consent to disclosure your health information to another Part 2 addiction treatment program (as that term is defined in 42 C.F.R. § 2.11, a covered entity health care provider, or a business associate for treatment, payment or health care operations may be further disclosed by that Part 2 program, covered entity health care provider or business associate without your written consent provided that such disclosures are permitted by the Health Insurance Portability and Accountability Act (“HIPAA”) and HIPAA regulations.
  • If you paid in full for a service or health care item out of your own pocket, you can ask us not to share that information for the purpose of payment or our operations with your health insurer. We will agree to this restriction unless a law or contract provision with your health insurer requires us to share that information.

You have a right to list of those to whom we’ve disclosed your health information

  • You have a right to ask for a list of all disclosures (an “accounting) of your health information made with your consent in the three (3) years prior to the date of your request.
  • You also have a right to ask for a list of all disclosures of your health information made by an intermediary (i.e., a covered entity health care provider or the covered entity’s business associate) who received your information with your consent in the three (3) years prior to the date of your request.

Get a copy of this Notice
You can ask for a paper copy of this Notice at any time, even if you have agreed to receive the notice electronically. We will provide you with a paper copy promptly. A copy of this Notice is also available on our website at www.newseason.com.

File a complaint if you feel your privacy rights were violated

  • You can complain if you feel we have violated your rights by contacting our Privacy Officer at 407.351.7080 ext. 11140 or bill.sutton@cmglp.com.
  • You can file a complaint with the U.S. Department of Health and Human Services Office for Civil Rights by sending a letter to 200 Independence Avenue, S.W., Washington, D.C. 20201, calling 1-877-696-6775, or visiting www.hhs.gov/ocr/privacy/hipaa/complaints/.
  • We will not retaliate against you for filing a complaint.

You have some choices in the way that we use and share information as we:

  • Communicate with your other healthcare providers
  • Communicate with your health insurance plan
  • Speak with your family and friends about your treatment
  • Create awareness in your community about opioid use disorder

For certain health information, you can tell us your choices about what we share. If you have a clear preference for how we share your information in the situations described below, talk to us. Tell us what you want us to do, and we will attempt to follow your instructions.

In these cases, you have both the right and choice to tell us to:

  • Share information with your other health care providers, their business associates or your health insurer
  • Share information with your family, close friends, or others who are supporting you in your treatment
  • Share information in a disaster relief situation

If you're unable to tell us your preference if, for example, you are unconscious or require emergency medical care, we may choose to share your information if we believe it is in your best interest. We may also share your information when needed to lessen a serious and imminent threat to health or safety.

In these cases we never share your information unless you give us written permission:

  • Participating in community awareness activities
  • Partnering with non-profit entities to provide additional services to our patients
  • Disclosing the counseling notes created during the course of your treatment

In the case of fundraising:

  • We may contact you as part of our fundraising efforts, but only if you give the right to do so. Before we contact you, you will be given the opportunity to tell us not to contact you for anything that concerns our fundraising efforts.

How do we typically use or share your health information?
We typically use or share your health information in the following ways.

Providing treatment to you (“Treatment”)
We can use your health information and share it with other medical and behavioral health professionals who are treating you.

Example: The clinic’s medical doctor who is treating you speaks with your counselor about your overall health condition.

Running our organization (“Operations”)
We can use and share your health information to run our organizations, improve your care, and contact you when necessary.

Example: We use your health information to manage your treatment and services and keep your medical records up to date.

Billing for the services provided to you (“Payment”)
We can use and share your health information to bill and receive payment from health insurers, including Medicare, Medicaid and commercial health insurance plans.

Example: We give information about you to your health insurance plan so it will pay for the services we provide to you.

PLEASE NOTE THAT FOR TREATMENT, OPERATIONS AND PAYMENT PURPOSES ONLY, YOU MAY PROVIDE A SINGLE, ONE-TIME CONSENT FOR ALL USES AND DISCLOSURES OF YOUR INFORMATION.

How else can we use or share your health information? Under federal law, there are a few limited instances where we can share your health information without your consent. These instances are:

  • Disclosures to emergency medical personnel in response to a bona fide medical emergency
  • Bona fide scientific research provided that the research entity meets all of the applicable requirements of the HIPAA regulations
  • Management audits, financial audits and program evaluations by entities who are legally authorized to perform such audits and evaluations
  • To report suspected incidents of child abuse and neglect
  • To report crimes occurring on a clinic’s premises or against a clinic employee

Comply with the law
We will share information about you if state or federal laws require it, including with the U.S. Department of Health and Human Services if that agency is assessing our compliance with federal privacy laws.

Responding to lawsuits and legal actions
Your health information or testimony about your health information will not be used or disclosed in any civil, criminal, administrative or legislative proceeding involving you without your written consent or a court order. Your health information shall only be used or disclosed based on a court order after notice and an opportunity to be heard is provided to you and us as required by 42 U.S. Code § 290dd-2 and 42 C.F.R. Part 2. Any court order authorizing the use of disclosure of your health information must be accompanied by a subpoena or other similar legal document requiring disclosure before your health information is used or disclosed.

PLEASE NOTE THAT FOR ANY OTHER USES AND DISCLOSURES OF YOUR INFORMATION THAT ARE NOT SPECIFICALLY MENTIONED OR OTHERWISE DESCRIBED IN THIS NOTICE, WE WILL NOT MAKE SUCH USES OR DISCLOSURES WITHOUT YOUR EXPRESS WRITTEN CONSENT.

  • We are required by law to maintain the privacy and security of your protected health information, and to provide you with a notice of our legal duties and privacy practices with respect to your health information.
  • We will let you know promptly if a breach occurs that may have compromised the privacy or security of your health information.
  • We are required to abide by the terms of this Notice and provide you a copy of it upon request.
  • We will not use or share your information other than as described in this Notice unless you tell us we can in writing. If you tell us we can, you may change your mind at any time. Let us know in writing if you change your mind.

Changes to the Terms of this Notice
We reserve the right to make changes to the terms of this Notice, and the changes will apply to all health information we have about you. A new notice will be available to you upon request, at our centers, and on our web site at www.newseason.com.

Acknowledgment:
By signing below, I acknowledge that I have received this Notice of Privacy Practices and have been offered an opportunity to request restrictions on certain uses and disclosures of my protected health information.

Overview

The confidentiality of alcohol and drug abuse patient records maintained by this program is protected by federal law and regulations. Generally, the program may not disclose any information about any patient, except under the following exceptions:

Conditions Permitting Disclosure
  1. Internal program communications
  2. Communications that do not disclose the identity of the patient
  3. Proper written consent provided by the patient
  4. Communications during medical emergencies
  5. Court-ordered disclosures
  6. Communication with law enforcement officials regarding crimes committed by patients on clinic premises or against clinic employees
  7. Communications in conjunction with research, audit, or evaluation
  8. Reporting of suspected child abuse and neglect
  9. Qualified service organization agreement (QSOA)

Violations of the federal law and regulations by a program are a crime. Suspected violations may be reported either at the program or against any person who works for the program or about any threat to commit such a crime.

The center is required by federal law to provide you with a copy of the policy outlined above. A copy of this policy is contained in the Patient Handbook.

Patient’s Confidentiality Policy

State and federal law protect your records and the fact that you are enrolled in our program. You will receive further information in this regard elsewhere in the intake process. The purpose of this notice is to inform you of our expectations for the confidentiality YOU extend to OTHER PATIENTS. We expect you to respect the confidentiality of other patients you know or meet while you are in treatment at our center. In other words, what you see here and what you hear here, must stay here. Do not violate another person’s confidentiality by carrying tales out of the center.

I have read and understand Federal Confidentiality Rule and Regulations as they apply to my treatment and the treatment of all other patients at New Season (For details, see 42 CFR, Part 2).

Please provide a signature.
Clear - Please sign the Acknowledgment of Services Offered section.
Date: 11/19/2025

Patient Name:

Date: 11/19/2025

As a client receiving addiction services through Telehealth methods with , I understand there are both benefits and limitations to this service; I also understand the following:

  1. This service is provided using secure technology (including but not limited to video, phone, text, and email) and may not involve direct, in person communication. I will need uninhibited access to and familiarity with the appropriate technology to participate in the service provided.
  2. These services rely on secure technology, which allows for greater convenience in service delivery; although we take every precaution to ensure continued confidentiality of your personal information, some risks still apply. The inherent risks in transmitting information over the internet include, but are not limited to, breaches of confidentiality, theft of personal information, and disruption of service due to technical difficulties.
  3. My Telehealth provider and I will regularly reassess the appropriateness of continuing to deliver services to me through the use of technology.
  4. Exchange of documentation may not be direct and any paperwork exchanged will likely be exchanged through secure electronic means or through postal delivery.
  5. Upon initiation of remote Telehealth services, my emergency contact person will be confirmed by my Telehealth provider and I will have the opportunity to designate an alternate individual who may be contacted in the case that an emergency arises outside of the clinic, during the course of my Telehealth care.
  6. If a need for an in person counseling session arises, it is my responsibility to contact this office for an in person counseling appointment. I understand that an opening may not be immediately available and that I will need to provide transportation to and from the appointment.
  7. I understand that my participation in Telecounseling and/or Telemedicine services is voluntary.
  8. There may be a need to communicate by other methods during times of service disruption; if there is a disruption of services for either the Telehealth provider or the patient, the Telehealth provider or member of the Telehealth team will attempt to contact within 24 hours to reschedule.
  9. My Telehealth provider or designee will respond to email communications and routine messages within 48 business hours of receipt of the email.
  10. It is my sole responsibility to ensure I have a stationary private setting for my Telehealth service and maintain my privacy during remote appointments..
  11. The laws and professional standards that apply to in-person counseling and medical services also apply to Telehealth services.
  12. This document does not replace other agreements, contracts, or documentation of informed consent.
Please provide a signature.
Clear - Please sign the Telehealth Informed Consent section.
Date: 11/19/2025

Patient Name:

Date: 11/19/2025

Please answer each of the following questions.

These questions are not intended to embarrass but are intended to help your counselor/case manager discuss with you these high-risk practices which have been shown to increase the risk of HIV/AIDS, and also to help you decide whether you wish to receive an HIV test.

  1. Have you ever used a needle to take drugs, including steroids, either intravenously (IV), intramuscularly (IM) or subcutaneously (Sub-Q) or skin-popping?
  2. Have you ever shared needles or works with anyone?
  3. Have you ever forgotten what you did when you were high?
  4. Have you ever had sex while you were high?
  5. Have you ever engaged in sex, willingly or unwillingly, while you were in jail or prison?
  6. Have you ever exchanged money or drugs for sex?
  7. Have you had more than one sex partner in the past year?
  8. Did you receive a blood transfusion or blood products between 1977 and 1985?
  9. Have you ever had Herpes, Hepatitis B, Syphilis, Gonorrhea, Chlamydia, or sores on the sex organs?
  10. Have you ever shared works or a needle with someone you now know is HIV positive or has AIDS?
  11. For men only – Have you ever had male to male sex?
  12. Have you ever had sex with anyone who would answer YES to any of the above questions?
  13. Do you think you have Tuberculosis (TB)?
  14. Have you ever tested positive on a skin test for Tuberculosis?
  15. Have you experienced any of the following symptoms within the past three months?
    • Frequent cough lasting more than two weeks?
    • Coughing up blood?
    • Night sweats?
    • Weight loss?
    • Loss of appetite?
    • Fever?
    • Fatigue?
  16. Do you want to be tested for HIV?
  17. Do you have any kind of lung disease?
Procedures Based on Assessment Outcome Following Assessment:

The absence of any reported symptoms (all NO answers) clears the way for further routine intake procedures. The presence of any reported symptoms (all YES or UNSURE answers, except #4) requires further evaluation, see and follow instructions on bottom of this page. The presence of any signs or symptoms suggestive of TB requires further evaluation. In this Center, issue the patient the NIOSH approved facemask and ask him or her to wear the mask until seen by the physician. Instruct the patient to use the tissues provided and cover his/her mouth and nose when coughing or sneezing if he/she must remove the mask when coughing or Sneezing. Promptly present the patient to the physician for evaluation and admissions processes, ahead of any other patients, by informing the physician of the possible suspicion of TB and your precautions. If the patient is admitted to treatment he or she must receive an immediate Mantoux PPD skin test with instructions for reading the skin test within one to three days. If the Mantoux PPD test indicates a negative reaction, routinely schedule the patient for his or her second Mantoux PPD test.If the Mantoux PPD test indicates a positive reaction, immediately refer the patient to the health department or his or her family physician for determinations of infectious status. Treat any such patient as potentially infectious by referring to and following the required actions found in the TB Control Plan in the Policy and Procedures Manual.

According to the FDA, “Methadone may be expected to have additive effects when used in conjunction with alcohol, other opioids or CNS depressants, or with illicit drugs that cause central nervous system depression. Deaths have been reported when Methadone has been abused in conjunction with benzodiazepines.”

I have read the above information and I understand the risks and/or contraindications of mixing alcohol and benzodiazepines with Methadone.

DRUG INTERACTIONS WITH METHADONE

Mixed agonist/antagonist medications, partial agonist medications and antagonist medications must not be used as they will precipitate opiate withdrawal syndrome.

  • Mixed Agonist/Antagonist Medications:
  • Pentazocine (Talwin)
  • Butorphanol (Stadol)
  • Nalbuphine (Nubain)
  • Partial Agonist Medications:
  • Buprenorphine (Subutex)
  • Buprenorphine/Naloxone (Suboxone)
  • Antagonist Medications:
  • Naltrexone (Revia, Vivitrol)
  • Naloxone (Narcan)
  • Other Considerations:
  • Meperidine and Propoxyphene should also be avoided due to potential risk of seizures.
  • There have been individual case reports indicating that Ultram/Ultracet may cause opiate withdrawal.
Please provide a signature.
Clear - Please sign the FDA Warning section.
Date: 11/19/2025
  • Date: 11/19/2025
  • Patient Name:
  • Date of Birth:
  • Patient State ID or Driver's License number:
Disclosure Purpose Statement for Central Registry

Authorize: to disclose my photograph and demographic information (Name, Alias, last 4 digits SSN, gender, DOB, admit date, Medication (type, form and dose), discharge date, reason, and last dose of medication) for admission to all Medication Assisted Treatment Programs, including programs that open in the future, within the state of Missouri and any other state that participates in the Central Registry. The information will be shared via secured electronic transmission.

The purpose for such disclosure is to prevent my dual enrollment in other OTP as well as provide assistance to treatment facility staff when they are providing emergency medication services during a disaster. This consent for disclosure is in compliance with Federal Confidentiality Laws (Federal Register, Vol. 4-Number 127, or July 1, 1975 subpart 2.31, 2.34) and 65D-30 and as amended.

Central Registry Acknowledgements

I hereby specifically authorize this clinic, known as: I hereby authorize the above clinic to disclose the above described information as permitted by State Law to The Central Registry. I further authorize The Central Registry to transmit and disclose the above described information to any clinic that I may be enrolled to prevent my dual enrollment. I further authorize the use of information held in the Central Registry to assist me in times of emergencies/disasters to receive medication elsewhere should the clinic listed above be forced to Close.

Acknowledgement of Understanding, Part 1

By placing a checkmark next to "I Agree" after each of the following statements and my signature on this form, I confirm my understanding and acceptance of the following:

I understand my records are protected under the Federal Confidentiality Regulations and may not be disclosed without my express written consent, unless otherwise provided for in the regulations. I also understand I may revoke this consent at any time except to the extent that action has been taken in accordance with it, and in any event, this consent expires automatically as set forth below.

I understand the above information will be maintained in the Lighthouse Software Systems, LLC (“LHSS”) central registry system for purposes of my participation in a Central Registry within this state named above, and also for the purpose of aiding my care in times of disaster and dual enrollment verification to prevent multiple medication assisted treatment program enrollments. LHSS is located at 17352 Derian Ave, Irvine, CA 92614. The Central Registry will contain presently prescribed medication(s) used for my treatment and my schedule of dosing records. This information will reside in the LHSS Central Registry system while I remain a patient at this clinic and will be available to staff where I may present for admission or emergency medication services for up to 60 days after my discharge from treatment at this location. My name will be encrypted in the LHSS Central Registry System database with technology that will meet HIPAA compliance requirements.

I understand when any clinic which participates in the Central Registry requests information from the Central Registry and I am found to be enrolled in another clinic, the Central Registry will disclose the name, address, and telephone number of the clinic in which I am already enrolled to the requesting clinic.

Acknowledgement of Understanding, Part 2

I understand this is a limited disclosure for the purpose or purposes as stipulated above, and so indicated by the person whose records this information has been extracted from. “This information has been released and disclosed to you from records whose confidentiality is protected by Federal Regulations (42 CFR Part 2) and the Health Insurance Portability and Accountability Act of 1996 (HIPAA), 45 C.F.R. parts 160 and 164 which prohibit you from making any further disclosure of it without the specific written consent of the person to whom it pertains, or as otherwise permitted by such regulations. A general authorization for the release of Medical or other information is NOT sufficient for this purpose.”

I understand my consent is automatically revoked 60 days after my discharge.

I understand I may view and request a copy of the information described above and/ or in this form.

I understand this treatment facility named above gets no compensation from LHSS for using or disclosing health information noted above.

Acknowledgement of Understanding, Part 3

I voluntarily consent to have my mobile number be used by treatment facility staff to notify me through the Central Registry’s communication module to notify me about service disruptions and treatment reminder information.

I voluntarily consent to have my email be used by treatment facility staff to notify me through the Central Registry’s communication module to notify me about service disruptions and treatment reminder information.

I understand that the State may require additional information to be collected about me and entered into the Central Registry including but not limited to race, ethnicity and funding source.

Patient Notification

This program is required to notify each patient prior to admission that it cannot provide treatment or medication to a patient who is simultaneously receiving these same services from another treatment program unless the medication is being provided in response to an emergency or disaster that forced the closure of the patient’s regular home clinic.

Patient Statement

I am not receiving medication and/or treatment from another Medication Assisted Treatment facility, its satellite or an Office Based Opioid Treatment provider and I understand if I do not sign this statement I will not be admitted for treatment or provided emergency medication services.

I understand I might be denied treatment if I refuse to consent to a disclosure for purposes of this Central Registry, if permitted by state law. I will not be denied services if I refuse to consent to disclosure for other purposes. I also hereby release the OTP stated above from liability which may arise as a result of information disclosed under an authorization if such information disclosed is later used to my detriment.

I understand I can request a copy of this release of information at any time

I was offered a copy of the release of information and at this time:

** In the case of patients who are deceased, have been judged incompetent or otherwise unable to sign on their own behalf, please have the authorized representative sign here:

Please provide a signature.
Clear - Please sign the Consent For Central Registry Release section.
Date: 11/19/2025
Introduction

The Central Registry is operated by Lighthouse Software Systems, LLC., located at 17352 Derian Ave., Irvine, CA 92614. Lighthouse will not send any promotional, marketing or solicitation messages to you. Lighthouse will not sell, share or use your contact information for any purpose other than messages sent by your treatment provider. By providing your mobile number, you agree the Lighthouse Software Systems, LLC may send you periodic SMS or MMS messages containing but not limited to important clinic information generated by your PTO/NTP.

I understand that by voluntarily providing my mobile number and/or email address, I opt-in and agree to receive communications from The Central Registry on behalf of my treatment provider, .

I understand and hereby authorize my treatment provider to send messages from The Central Registry to me for a variety of purposes, including but not limited to:

  • Service disruption notifications
  • Emergency closures
  • Appointment reminders
  • Counseling/counselor reminders

I understand that the following data may be collected:

  • My mobile phone number
  • My mobile service provider’s number
  • My email address
  • Date and time of messages sent to me
  • Content of messages sent to me
  • Current Phone Number:
  • Current Email:
Standard Messaging Terms and Conditions
  • Message frequency will vary
  • You may unsubscribe at any time by texting the word STOP to (239)341-7182. You will receive a subsequent message confirming your opt-out request.
  • For help, send the word HELP to (239)341-7182 or email info@centralregistry.com.
  • Message and data rates may apply
  • United States Participating Carriers Include AT&T, T-Mobile®, Verizon Wireless, Sprint, Boost, U.S. Cellular®, MetroPCS®, InterOp, Cellcom, C Spire Wireless, Cricket, Virgin Mobile and others.
  • U.S. based carriers are not liable for delayed or undelivered messages.
  • You agree to notify us of any changes to your mobile number and update your account with us to reflect the change.
  • Data obtained from you in connection with this SMS service may include your cell phone number, your carrier’s name, and the date, time and content of your messages, as well as other information that you provide. We may use this information to contact you and to provide the services you request from us.
  • By subscribing or other using the service, you acknowledge and agree that we will have the right to change and/or terminate the service at any time, with or without cause and/or advance notice.
Please provide a signature.
Clear - Please sign the Central Registry Concent To Messaging section.
Date: 11/19/2025

I, understand that I am responsible for the payment of all fees under this program and do hereby promise to pay for all such fees. If I am eligible for insurance, I understand it is my responsibility to maintain my eligibility status. I am responsible to make the appropriate co-pays at the time of service and are responsible for any deductible amount required by the insurance plan. I further acknowledge that if my insurance carrier fails to pay and/or denies any services, I am responsible for payment. If my account for any unpaid fees or other charges is referred for collection, I agree to pay any and all attorney’s fees, collection fees, and court costs related to the collection of my account. Pursuant to Confidentiality of Substance Use Disorder Patient Records, 42 C.F.R., Part 2, I authorize Colonial Management Group, L.P. d/b/a New Season Treatment Centers (hereinafter "New Season") to disclose my name and any of my records to any outside party and/or collection agency that may be needed or required to pursue collection of any delinquent monies I am responsible for and further authorize the outside party and/or collection agency to utilize those records, as they may require to collect any delinquent monies which I owe to New Season.

I acknowledge treatment fees have been explained to me. I also understand that these fees are subject to change or adjustment over time.

Clinic Fees, as applicable:
  • Intake: None
  • Intensive Outpatient Program: Talk to your treatment team for more information.
  • Additional Urine Drug Screen: $10
  • Confirmation Urine Drug Screen: $ 35
  • Monthly Surcharge: None
  • Oral Swab: $10
Daily Medication Fees, as applicable:
  • Methadone Liquid: Please select a location above.
  • Methadone Tablet: Please select a location above.
  • Buprenorphine: Please select a location above.
  • Suboxone: Please select a location above.

I acknowledge and accept all terms and conditions related to the payment of the fees under my treatment.


Overview

I understand that I will be required to submit to periodic drug screens as required by state and federal rules, for the purposes of determining drug use.I understand the following rules apply:

Patient Acknowledgement
  1. I am expected to provide a drug screen sample upon request of any staff member. Daily medication dosage may be delayed until a sample is produced.
  2. I understand that I will be requested to submit to a drug screen on a random or unscheduled basis but at least once a month or more often as necessary, sometimes on a weekly basis.
  3. I understand that a refusal on my part to provide a sample shall count as a positive drug screen and may result in loss of privileges.
  4. I understand that a drug screen which contains a foreign matter or substance will be considered a positive drug screen and may result in loss of privileges. Evidence of dilution will also be considered positive.
  5. I understand that a cold bottle of urine shall count as a positive drug screen and may result in loss of privileges.
  6. I understand that purses, bags, jackets or heavy clothing will not be permitted in the restroom.
  7. I understand that a same-sex staff member may observe me as I produce a urine sample, and that a refusal to cooperate may result in loss of privileges.
  8. An attempt, whether successful or not, to defeat or cheat on urinalysis testing may result in loss of privileges.
Understanding/Consent

I understand and consent to these rules and agree to abide by them as a condition of my treatment.


Overview

Patient Name:

I acknowledge and affirm that I understand the services offered by this medical treatment facility:

Patient Acknowledgment
  1. This medical treatment facility offers methadone maintenance and detoxification for opiate addiction. Patients receive individually prescribed methadone medication from a licensed medical staff member. The methadone treatment program is staffed by employees from various professions including physicians, licensed practical nurses, pharmacists, and drug and alcohol counselors
  2. The clinic offers healthcare services including physical examinations and testing for TB, HIV, and Hepatitis-B
  3. Patients meet with a primary counselor for individual counseling, at minimum monthly. Patients will attend group counseling as outlined in their treatment plan. Family counseling is available as requested
  4. Patients receive case management services to access social services and referrals for vocational, educational, medical, family, legal, financial and psychiatric problems
  5. The clinic offers assessment and individual treatment planning services to address biopsychosocial, substance abuse and life needs
  6. This medical treatment facility provides the patient suffering from opiate addiction with health, social and rehabilitation services alongside medically prescribed medications to relieve withdrawal symptoms and reduce opiate cravings
  7. The medication treatment facility offers monthly urinalysis and referral to various support and self-help groups individualized to the patients needs
Please provide a signature.
Clear - Please sign the Acknowledgment of Services Offered section.
Date: 11/19/2025


To the best of my knowledge, I (Choose Pregnancy Status):

Besides the possible risks involved with the long-term use of opioid agonist medication, I further understand that the safety and effectiveness of opioid agonist medication treatment during pregnancy is well established, however it remains inadequate to guarantee that significant or serious side effects will not occur.

I understand that opioid agonist medication is transmitted to the unborn child and will cause physical dependence during the pregnancy and possible newborn withdrawal following delivery. Thus, if I am pregnant and suddenly stop taking opioid agonist medication, the unborn child may show signs of withdrawal, which may adversely affect my pregnancy or the child. I shall use no other drugs without approval of the Medical Director or their authorized assistant since these drugs, particularly as they might interact with opioid agonist medication, may harm me or my unborn child. I shall inform any other physician who sees me during the present or any future pregnancy, or who sees the child after birth, of my current or past participation in a narcotic treatment program in order that they may properly care for my child and me.

I understand that after the birth of my child that chest-feeding/breast-feeding is safe and encouraged provided there are no other medical reasons to avoid nursing the newborn. I understand that for a brief period following the birth, the child may show temporary irritability or other signs or symptoms of newborn withdrawal associated with the abrupt discontinuation (delivery) of opioid agonist medication. It is essential for the child's physician to know of my participation in a narcotic treatment program so that they may provide appropriate medical treatment for the child.

All the above possible effects of opioid agonist medication have been explained to me, and I understand that at present, studies conducted on the long-term use of the drug fail to ensure complete safety to my child. With full knowledge of this, I consent to its use and promise to inform the Medical Director or one of their assistants immediately if I become pregnant.

I certify that no guarantee or assurance has been made as to the results that may be obtained from narcotic addiction treatment. With full knowledge of the potential benefits and possible risks involved, I consent to narcotic treatment, since I realize that I would otherwise continue to be dependent on heroin or other narcotic drugs.


Patients who are pregnant or may become pregnant during treatment are required to meet the same financial obligations as other non-pregnant patients.

  1. Pregnancy does not change your financial obligations to New Season.
  2. Pregnant patients who fail to meet the clinic’s financial obligations will be provided with an individualized and medically supervised withdrawal (MSW) which shall be initiated upon consultation with your attending obstetrician.
  3. Your attending obstetrician will be informed in writing that you are being gradually withdrawn from opioid agonist medication maintenance.
  4. The safety of medically supervised withdrawal during pregnancy has been established with clinical experience as an evidencebased optional procedure.
  5. During medically supervised withdrawal, New Season will cooperate with your efforts to arrange for alternative care, including transfer to another opioid treatment program (OTP).
Please provide a signature.
Clear - Please sign the Child-bearing Potential Patient Acknowledgment section.
Date: 11/19/2025
Please affirm that you are the individual completing and submitting these forms.
X